New York State Common Retirement Fund’s PDS Biotechnology PDSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-224
Closed -$656 3301
2024
Q2
$656 Sell
224
-1,967
-90% -$6.29K ﹤0.01% 3315
2024
Q1
$8.68K Buy
2,191
+1,260
+135% +$6.49K ﹤0.01% 3196
2023
Q4
$4.63K Sell
931
-15,953
-94% -$79.3K ﹤0.01% 3223
2023
Q3
$85.3K Buy
16,884
+284
+2% +$1.56K ﹤0.01% 2801
2023
Q2
$83.5K Buy
+16,600
New +$109K ﹤0.01% 2986
2018
Q2
Sell
-1,135
Closed -$27K 3200
2018
Q1
$27K Buy
1,135
+270
+31% +$72.6K ﹤0.01% 3058
2017
Q4
$162K Hold
865
﹤0.01% 2846
2017
Q3
$186K Hold
865
﹤0.01% 2815
2017
Q2
$177K Hold
865
﹤0.01% 2905
2017
Q1
$158K Hold
865
﹤0.01% 2850
2016
Q4
$216K Hold
865
﹤0.01% 2748
2016
Q3
$180K Hold
865
﹤0.01% 2796
2016
Q2
$175K Buy
865
+510
+144% +$90.1K ﹤0.01% 2792
2016
Q1
$65K Buy
+355
New +$63.5K ﹤0.01% 3016

Other funds holding PDSB

New York State Common Retirement Fund's PDSB Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of PDS Biotechnology (PDSB) in Q3 2024, closing a stake of 224 shares — an estimated $656 sold.

New York State Common Retirement Fund first reported a position in PDSB in Q1 2016 and held it in 14 quarters. The position peaked at $216K in Q4 2016. 57 funds tracked by Wall St. Rank hold PDSB as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining PDS Biotechnology position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 224 PDS Biotechnology shares in Q3 2024, an estimated $656.
  • New York State Common Retirement Fund first reported a position in PDS Biotechnology in Q1 2016 and held it in 14 quarters.
  • New York State Common Retirement Fund's PDS Biotechnology position peaked at $216K in Q4 2016.
  • 57 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.